Aethlon Medical (0A6R) Ratios
Aethlon Medical Ratios
GB:0A6R's free cash flow for Q1 2027 was $-1.91B. For the 2027 fiscal year, GB:0A6R's free cash flow was decreased by $-9.15M and operating cash flow was $-1.90B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.85 | 3.13 | 3.40 | 10.03 | 9.95 |
| Quick Ratio | 3.85 | 3.13 | 3.40 | 10.03 | 9.95 |
| Cash Ratio | 3.47 | 2.90 | 2.97 | 9.66 | 9.36 |
| Solvency Ratio | -4.72 | -5.84 | -4.78 | -4.82 | -4.24 |
| Operating Cash Flow Ratio | -4.84 | -4.03 | -5.54 | -6.98 | -5.35 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.12M | $ 3.71M | $ 3.75M | $ 12.65M | $ 15.73M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.09 | 0.11 | 0.07 | 0.04 |
| Debt-to-Equity Ratio | 0.07 | 0.13 | 0.16 | 0.08 | 0.04 |
| Debt-to-Capital Ratio | 0.06 | 0.11 | 0.14 | 0.07 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.30 | 1.44 | 1.43 | 1.16 | 1.13 |
| Debt Service Coverage Ratio | -474.08 | -1289.78 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -507.49 | -924.06 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.52 | 4.23 | 3.74 | 5.89 | 4.94 |
| Net Debt to EBITDA | 0.69 | 0.37 | 0.37 | 1.14 | 1.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -2072.05% | -3542.53% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -2030.10% | -3500.48% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -2072.05% | -3542.53% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -2094.89% | -3542.53% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -2094.89% | -3540.90% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -2094.89% | -3542.53% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 99.95% |
| EBT Per EBIT | 98.05% | 143.32% | 96.61% | 101.10% | 100.00% |
| Return on Assets (ROA) | -112.92% | -181.91% | -148.05% | -68.71% | -53.64% |
| Return on Equity (ROE) | -146.36% | -261.31% | -211.71% | -79.86% | -60.80% |
| Return on Capital Employed (ROCE) | -149.27% | -171.08% | -196.95% | -74.35% | -59.23% |
| Return on Invested Capital (ROIC) | -139.64% | -161.80% | -188.42% | -73.12% | -58.81% |
| Return on Tangible Assets | -112.92% | -181.93% | -148.07% | -68.71% | -53.65% |
| Earnings Yield | -97.04% | -59.93% | -35.10% | -19.27% | -6.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 2.30 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.25 | 0.26 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 158.78 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 158.78 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 158.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -10.40 | -49.01 | -40.31 | -51.14 | -66.17 |
| Free Cash Flow Per Share | -10.40 | -49.01 | -41.31 | -55.74 | -68.54 |
| Dividend Paid and CapEx Coverage Ratio | -1889.41 | -3822766.00 | -40.38 | -11.14 | -27.97 |
| Capital Expenditure Coverage Ratio | -1889.41 | -3822766.00 | -40.38 | -11.14 | -27.97 |
| Operating Cash Flow Coverage Ratio | -20.78 | -11.77 | -10.77 | -8.69 | -13.39 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -18.29 | -33.20 |
| Free Cash Flow Yield | -95.02% | -34.22% | -29.85% | -18.33% | -5.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.03 | -1.67 | -2.85 | -5.19 | -16.55 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 108.74 | 586.05 |
| Price-to-Book (P/B) Ratio | 1.51 | 4.36 | 6.03 | 4.15 | 10.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.05 | -2.92 | -3.35 | -5.45 | -17.04 |
| Price-to-Operating Cash Flow Ratio | -1.05 | -2.92 | -3.43 | -5.94 | -17.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.02 | 0.17 | 0.31 | -2.00 |
| Enterprise Value Multiple | -0.39 | -1.34 | -2.47 | -4.21 | -15.15 |
| Enterprise Value | 2.68M | 17.49M | 30.28M | 49.12M | 156.05M |
| EV to EBITDA | -0.39 | -1.34 | -2.47 | -4.21 | -15.15 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 85.53 | 530.50 |
| EV to Free Cash Flow | -0.38 | -2.29 | -2.92 | -4.29 | -15.43 |
| EV to Operating Cash Flow | -0.38 | -2.29 | -2.99 | -4.68 | -15.98 |
| Tangible Book Value Per Share | 7.26 | 32.84 | 22.94 | 73.33 | 115.10 |
| Shareholders’ Equity Per Share | 7.26 | 32.84 | 22.95 | 73.34 | 116.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 2.80 | 1.99 |
| Net Income Per Share | -10.63 | -85.82 | -48.58 | -58.57 | -70.57 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.97 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 4.78 | 7.96 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 13.08 | 19.34 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 1.83 | 2.55 |
| Income Quality | 0.98 | 0.57 | 0.83 | 0.87 | 0.94 |
Currency in USD
